Alec Stranahan

Stock Analyst at B of A Securities

(0.43)
# 2720
Out of 5,441 analysts
34
Total ratings
Success rate
Average return
Main Sectors:
16 Stocks
Name Action PT Current % Upside Ratings Updated
NVAX Novavax
Maintains: Neutral
10 9
8.04 11.94% 4 Jul 22, 2025
KRYS Krystal Biotech
Maintains: Buy
193 192
137.58 39.56% 4 Jul 22, 2025
BEAM Beam Therapeutics
Upgrades: Buy
42 42
17.16 144.76% 1 Mar 28, 2025
YMAB Y-mAbs Therapeutics
Maintains: Neutral
14 12
8.52 40.85% 5 Mar 5, 2025
CADL Candel Therapeutics
Initiates Coverage On: Buy
15
6.21 141.55% 1 Feb 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
28 25
5.91 323.01% 4 Jan 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
13 11
1.7 547.06% 1 Jan 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
5 5
1.48 237.84% 2 Jan 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
24 6
3.72 61.29% 2 Nov 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
13 15
2.2 581.82% 1 Aug 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
48 55
34.71 58.46% 3 Jul 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
42
7 500% 1 May 19, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underperform
5 6
26.4 -77.27% 2 Dec 29, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
60 5
0.84 495.24% 1 Dec 2, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
45
46.99 -4.23% 1 Dec 1, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
58
n/a n/a 1 May 20, 2022